Halted NIH Clinical Trials List Reveals Slashed Treatments for Cancer, COVID and Minority Health
On Nov. 20, 2025, the National Institutes of Health (NIH) has canceled funding for at least 383 clinical…
On Nov. 20, 2025, the National Institutes of Health (NIH) has canceled funding for at least 383 clinical…
On Nov. 19, 2025, the governing board of the Cancer Prevention and Research Institute of Texas (CPRIT) approved…
On Nov. 19, 2025, a study by researchers from Nanyang Technological University (NTU) Singapore announced they had discovered…
On Nov. 19, 2025, researchers announced a Ōtākou Whakaihu Waka-led study has produced a detailed blueprint of a…
On Nov. 19, 2025, Novartis, a leading global innovative medicines company, announced plans to expand its operations in…
On Nov. 18, 2025, CSL, Australia’s largest biotech company announced plans to expand its US presence with a…
On Nov. 18, 2025, Arrowhead Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved REDEMPLO…
On Nov. 18, 2025, Stanford Medicine researchers reported that a combination blood stem cell and pancreatic islet cell…
On Nov. 18, 2025, state officials in Utah report 84 measles cases in the state in a weekly…
On Nov. 17, 2025, Johnson & Johnson announced that it has entered into a definitive agreement to acquire…
On Nov. 17, 2025, Sandoz announced that TYRUKO® (natalizumab-sztn) is available to patients in the US. Developed by…
On Nov. 17, 2025, in a major step forward for cancer care, researchers at ChristianaCare’s Gene Editing Institute…
On Nov. 17, 2025, a JAMA published study found that more than 74,000 people have had their lives…
On Nov. 14, 2025, the Washington State Department of Health reported that a Grays Harbor resident who was…
On Nov. 14, 2025, Merck and Cidara Therapeutics, a biotechnology company developing drug-Fc conjugate (DFC) therapeutics, announced that…
On Nov. 13, 2025, the World Health Organization (WHO) reported that Health authorities in Ethiopia are carrying out…
On Nov. 13, 2025, Legend Biotech announced the official opening and ribbon cutting of its new, state-of-the-art research…
On Nov. 13, 2025, a previously healthy New Jersey man has been identified by an allergist at the…
On Nov. 13, 2025, the U.S. Food and Drug Administration (FDA) approved multiple denosumab biosimilars, enhancing market access…
On Nov. 12, 2025, a study led by the Hebrew University of Jerusalem, and the Laboratory of Entomology…
On Nov. 12, 2025, Allen Institute researchers and engineers have unlocked an the world’s most comprehensive AI-powered tool…
On Nov. 12, 2025, a team of University of California, Berkeley-led researchers reported in Nano Letters that they…
On Nov. 12, 2025, Stanford Medicine scientists have found that the Epstein-Barr virus can convert B cells it’s…
On Nov. 12, 2025, UK researchers reported a test-negative, case-control study across 14 hospitals in England finds that the…
On Nov. 11, 2025, the United Kingdom government announced that animal testing in science is set to be…
On Nov. 11, 2025, China introduced a visa that will allow young foreign researchers in science, technology, engineering…
On Nov. 10, 2025, a study led by the University of Liverpool reported that existing evidence does not…
On Nov. 10, 2025, Canada has lost its measles elimination status after nearly three decades due to its…
On Nov. 9, 2025, scientists from the Center for Marine Environmental Sciences, University of Bremen reported they had…
On Nov. 7, 2025, research published today in Cell Reports Medicine reveals key biological differences that may explain why…